Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

4
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
4
Neural Regulation01:37

Neural Regulation

45.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.2K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

3.2K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.2K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

5
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
5
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

6
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
6

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complete Resection of a Middle Mediastinal Malignant Peripheral Nerve Sheath Tumour via a Transmanubrial Osteomuscular Sparing Approach: A Case Report.

Respirology case reports·2026
Same author

Robot-Assisted Lobectomy for Lung Cancer Complicated by Lymphangioleiomyomatosis.

Surgical case reports·2026
Same author

Radiologists' diagnostic confidence in surgically referred pulmonary nodules: a routine computed tomography report retrospective analysis.

BMC pulmonary medicine·2026
Same author

Surgical outcomes and long-term prognosis of patients with tracheobronchial adenoid cystic carcinoma.

Nagoya journal of medical science·2026
Same author

A comparison of robot-assisted thoracic surgery and median sternotomy for the treatment of early-stage thymoma: a propensity score matching study.

General thoracic and cardiovascular surgery·2026
Same author

Tissue-derived extracellular vesicle profiling identifies GLUT1 enabling ultrasensitive circulating quantification and early detection of non-small cell lung cancer.

Clinical and translational medicine·2026

Related Experiment Video

Updated: Apr 19, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K

[Neuronal dysfunction in multiple sclerosis].

Tetsuya Mizuno1

  • 1Department of Neuroimmunology, Research Institute of Environmental Medicine, Nagoya University.

Rinsho Shinkeigaku = Clinical Neurology
|December 19, 2014
PubMed
Summary
This summary is machine-generated.

Microglia contribute to neuroinflammation in multiple sclerosis (MS) by releasing toxic molecules. However, damaged neurons release factors that promote microglial neuroprotection, offering therapeutic insights for MS cortical damage.

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

5.4K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.7K

Related Experiment Videos

Last Updated: Apr 19, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

5.4K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.7K

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Cortical damage mechanisms in multiple sclerosis (MS) are not fully understood.
  • Microglia, the CNS resident immune cells, drive chronic neuroinflammation in MS cortical lesions.
  • Microglia release neurotoxic factors including inflammatory cytokines (IFN-γ, IL-1β), reactive oxygen species (ROS), and glutamate.

Purpose of the Study:

  • To elucidate the precise mechanisms of cortical damage in MS.
  • To investigate the dual role of microglia in MS neuroinflammation and neuroprotection.
  • To identify potential therapeutic targets for mitigating MS-related cortical damage.

Main Methods:

  • Analysis of inflammatory mediators produced by microglia (e.g., IL-1β, ROS, glutamate).
  • Investigation of neuronal signaling pathways involved in microglial activation (e.g., NLRP3, Th17 cells, gap junctions).
  • Examination of neuroprotective factors released by damaged neurons (e.g., fractalkine, FGF-2) and their downstream effects.

Main Results:

  • Microglial activation, induced by factors like NLRP3 and GM-CSF-producing Th17 cells, leads to the release of neurotoxic substances.
  • Damaged neurons release fractalkine and FGF-2, which exert anti-inflammatory and anti-oxidant effects on microglia.
  • Fractalkine promotes microglial debris clearance via MFG-E8, while FGF-2 enhances microglial migration through the FGFR3-Wnt-ERK pathway.

Conclusions:

  • Microglia play a complex role in MS cortical lesions, contributing to both damage and potential repair.
  • Neuronal-derived factors like fractalkine and FGF-2 offer a promising avenue for developing neuroprotective therapies in MS.
  • Understanding these molecular interactions is crucial for future therapeutic strategies targeting cortical damage in MS.